|
2024
|
Invention
|
Separation of metal ions by liquid-liquid extraction.
Provided herein are separation processes f... |
|
2023
|
Invention
|
Methods and compositions related to toxicity associated with cell therapy.
Provided are methods,... |
|
|
Invention
|
Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers. ... |
|
|
Invention
|
Systems and methods for evaluating tissue of a subject. The present disclosure is directed to rel... |
|
2022
|
Invention
|
Protective antibodies against respiratory viral infections. Antibodies that protect against respi... |
|
|
Invention
|
Methods of modeling in vivo efficacy of drug combinations for treatment of viral infections.
Met... |
|
|
Invention
|
Methods of modeling in vivo efficacy of drug combinations for treatment of viral infections. Meth... |
|
|
Invention
|
Systems and methods to link cd40 signaling to antigen binding. Systems and methods to link CD40 s... |
|
|
Invention
|
Methods and compositions for enhancing cd4+ phenotype for adoptive t cell therapy. The disclosure... |
|
2021
|
Invention
|
Immunogenic compositions. Provided herein are compositions comprising novel MHC class II T cell e... |
|
|
Invention
|
Compositions and methods for cellular immunotherapy. The present application concerns chimeric co... |
|
|
Invention
|
Cell-penetrating peptides and peptide complexes and methods of use. Described herein are peptides... |
|
|
Invention
|
Compositions and methods for selective depletion of target molecules. Described herein are compos... |
|
|
Invention
|
Pd-l1 binding peptides and peptide complexes and methods of use thereof. Described herein are cys... |
|
|
Invention
|
Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof.
Hematopoeiti... |
|
|
Invention
|
Therapeutic targeting of mesothelin in acute myeloid leukemia with chimeric antigen receptor t ce... |
|
|
Invention
|
Compositions and methods to promote thymic function. Compositions and methods to promote thymic f... |
|
|
Invention
|
Synthetic introns for targeted gene expression. The disclosure provides artificial nucleic acid i... |
|
|
P/S
|
Charitable fundraising Educational services, namely, teaching healthy cooking and eating to cance... |
|
|
P/S
|
Charitable fund raising Educational services, namely, teaching healthy cooking and eating to canc... |
|
|
Invention
|
Specific targeting of tumor-infiltrating regulatory t cells (tregs) using icos and il-1r1. The di... |
|
|
Invention
|
Compositions and methods for treating mage-a1-expressing disease. The present disclosure provides... |
|
|
Invention
|
Immunotherapy targeting sox2 antigens. The present disclosure provides compositions and methods f... |
|
|
Invention
|
Immunotherapy targeting pbk or oip5 antigens. The present disclosure provides compositions and me... |
|
|
Invention
|
Improved high efficiency targeted in situ genome-wide profiling. The disclosure provides methods ... |
|
|
P/S
|
Downloadable electronic publications in the nature of newsletters, pamphlets, brochures, magazine... |
|
|
Invention
|
Iodide for treatment of nonthyroidal illness syndrome. The present invention relates to the use o... |
|
|
Invention
|
Stable coronavirus proteins and vaccine compositions thereof. Provided herein are compositions an... |
|
|
Invention
|
Anti-fibrotic composition and related methods. in vitroin vitro. The compound of Formula (I) can ... |
|
|
Invention
|
Compositions and methods for enhancing cancer immunotherapy. The disclosure provides methods of e... |
|
|
Invention
|
Biomarkers for detection of lung cancer. vitrovitro methods for diagnosing lung cancer in a subje... |
|
|
Invention
|
Neutralizing monoclonal antibodies against covid-19. The disclosure provides antibodies, antibody... |
|
|
Invention
|
Integration of large adenovirus payloads. The current disclosure provides recombinant adenoviral ... |
|
|
Invention
|
In vivo gene therapy. in vivoin vivoin vivo in vivoin vivoin vivo gene therapy including administ... |
|
|
Invention
|
Systems and methods for identifying associations between microbial strains and phenotypic feature... |
|
|
Invention
|
Anti-mesothelin antigen-binding molecules and uses thereof. e.g.e.g., CD3) and activate T cells i... |
|
|
Invention
|
Anti-cd33 antibodies and uses thereof. A suite of novel anti-CD33 antibodies is described. The pr... |
|
|
Invention
|
Chimeric antigen receptors targeting cd33. Chimeric antigen receptors (CARs) with binding domains... |
|
|
Invention
|
Human anti-cd33 antibodies and uses thereof. A suite of novel human anti-CD33 antibodies is descr... |
|
|
Invention
|
Augmenting antigen-negative cell death in antigen-targeted immunotherapies. in vivoin vivo action... |
|
|
Invention
|
Tunable extended release hydrogels.
The present disclosure describes an immunotherapy delivery h... |
|
|
Invention
|
Tunable extended release hydrogels. The present disclosure describes an immunotherapy delivery hy... |
|
2020
|
Invention
|
High affinity mage-a1-specific tcrs and uses thereof.
The present disclosure provides TCRs with ... |
|
|
P/S
|
Charitable fund raising; charitable fund raising in the area of research, prevention, detection, ... |
|
|
Invention
|
Cell population analysis using single nucleotide polymorphisms from single cell transcriptomes.
... |
|
|
Invention
|
T-cell immunotherapy specific for wt-1.
The present disclosure provides binding proteins specifi... |
|
|
Invention
|
Combinatorial car t cell and hematopoeitic stem cell genetic engineering for specific immunothera... |
|
|
Invention
|
Method for enhancing cellular immunotherapy.
Provided are methods and compositions directed to t... |
|
|
Invention
|
High avidity wt1 t cell receptors and uses thereof.
The present disclosure provides T cell recep... |
|
2019
|
Invention
|
T cell receptors specific for mesothelin and their use in immunotherapy.
Binding proteins specif... |
|
|
Invention
|
Chimeric receptor proteins and uses thereof.
The present disclosure provides fusion proteins wit... |
|
|
Invention
|
Immunotherapy targeting kras or her2 antigens.
Binding proteins and high affinity recombinant T ... |
|
|
P/S
|
Promoting public awareness about cancer and cancer research Charitable fund raising Organization ... |
|
2018
|
Invention
|
Binding proteins specific for 5t4 and uses thereof.
The present disclosure provides compositions... |
|
2016
|
P/S
|
Charitable fundraising services |
|
2014
|
P/S
|
Printed publications, namely, newsletters, pamphlets, brochures, magazines, instruction sheets an... |
|
2013
|
P/S
|
Printed publications, namely, newsletters, pamphlets, and brochures on cancer research, clinical ... |
|
2006
|
P/S
|
Providing recognition and incentives by the way of awards to baseball players who exemplify honor... |
|
2003
|
P/S
|
Charitable fund raising |
|
1997
|
P/S
|
printed publications, namely, newsletters, pamphlets, brochures, magazines, instruction sheets an... |
|
|
P/S
|
[ reagents and antibodies for in vitro scientific, diagnostic or research use ] medical consultin... |
